CANLYTx™ (CANCER + ANALYTICS) is a molecular data analytics and simulation engine that explores the whole exome data of the patient’s tumor DNA to demystify the complex genomic anomalies unique to that cancer. An individualized treatment regimen based on these genomic findings is presented in a detailed report to the clinicians.
Benefits
Wholistic approach for the entire functional part of the genome; fully automated analytics algorithm; database of 200,000+ entries with various evidence levels; multiple evidence-based recommendations for off-label treatment; competitive price point
Accessibility Controls